How do bacteria resist human antimicrobial peptides?
Top Cited Papers
- 1 April 2002
- journal article
- review article
- Published by Elsevier in Trends in Microbiology
- Vol. 10 (4), 179-186
- https://doi.org/10.1016/s0966-842x(02)02333-8
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Inhibition of Intracellular Macromolecular Synthesis inStaphylococcus aureusby Thrombin‐Induced Platelet Microbicidal ProteinsThe Journal of Infectious Diseases, 2002
- Structure–function relationships in the tryptophan‐rich, antimicrobial peptide indolicidinJournal of Peptide Science, 2001
- Nasal Carriage as a Source ofStaphylococcus aureusBacteremiaNew England Journal of Medicine, 2001
- The d -Alanine Residues of Staphylococcus aureus Teichoic Acids Alter the Susceptibility to Vancomycin and the Activity of Autolytic EnzymesAntimicrobial Agents and Chemotherapy, 2000
- In Vitro Resistance of Staphylococcus aureus to Thrombin-Induced Platelet Microbicidal Protein Is Associated with Alterations in Cytoplasmic Membrane FluidityInfection and Immunity, 2000
- Phylogenetic Perspectives in Innate ImmunityScience, 1999
- Antimicrobial peptides from plateletsDrug Resistance Updates, 1999
- Widespread expression of beta‐defensin hBD‐1 in human secretory glands and epithelial cellsFEBS Letters, 1996
- Chronic granulomatous disease in adultsThe Lancet, 1996
- Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity.Journal of Clinical Investigation, 1989